ZAWYA: Jamjoom Pharma signs MOU with the Ministry of Health in Saudi Arabia to develop healthcare talents

About this update from Jamjoom Pharmaceuticals Factory Co.

Jeddah: Jamjoom Pharma, a leading Saudi pharmaceutical healthcare company in the Middle East and Africa (MEA), signed a Memorandum of Understanding (MoU) with the General Administration of Pharmaceutical Care at the Ministry of Health Saudi Arabia, aiming to support the development of healthcare and pharmaceutical professionals through training programs and educational initiatives, contributing to enhancing the quality of healthcare services and achieving the objectives of Saudi Vision 2030.The agreement comes as part of Jamjoom Pharma’s broader strategy to strengthen its role as an active national partner in advancing the healthcare sector by investing in healthcare and pharmaceutical talent development, supporting community awareness programs, and expanding collaboration with government health entities.Under the MoU signed between Jamjoom Pharma and the General Administration of Pharmaceutical Care at the Ministry of Health Saudi Arabia, the two parties will collaborate on implementing developmental programs across administrative, technical, and specialized fields, in addition to designing and developing curriculums in line with the professional global standards, and organizing workshops, seminars, and forums related to pharmaceutical training and development. The collaboration will also include assessing the training needs of HCPs, providing professional consultations, evaluating the impact of training programs, and exchanging expertise in professional development fields.The MoU was signed by Ahmed Samir Al Khouly, General Manager at Jamjoom Pharma Saudi Arabia, and Mohammed Alshennawi, General Director of the General Administration of Pharmaceutical Care at the Ministry of Health, KSA, in the presence of officials from both parties.Commenting on the agreement, Dr. Ahmed Samir Al Khouly, General Manager at Jamjoom Pharma Saudi Arabia, stated: “The MoU with the Ministry of Health’s General Administration of Pharmaceutical Care reflects Jamjoom Pharma’s commitment to supporting the development of pharmaceutical competencies and enhancing specialized professional training programs, contributing to empowering healthcare practitioners to keep pace with the latest developments in the healthcare and pharmaceutical sectors, while supporting the Kingdom’s healthcare transformation goals.”For his part, Dr. Mohammed Alshennawi, General Director of the General Adm...

View stock analysis, news, and events for Jamjoom Pharmaceuticals Factory Co.